Literature DB >> 12630898

Construction of a new tumour necrosis factor fusion-protein expression vector for high-level expression of heterologous genes in Escherichia coli.

Wei Han1, Yingqi Zhang, Zhen Yan, Jihong Shi.   

Abstract

We report the construction and application of a new fusion-protein expression plasmid (TNFHis) for Escherichia coli. The plasmid contains both P(R) and P(L) promoters and is optimized to allow a higher level of expression of mature coding sequences. It also contains a six-histidine tag for convenient purification as well as thrombin and hydroxylamine recognition sites for cleaving heterologous protein. The potential use of this expression vector is demonstrated by comparing the expression levels of human tumour necrosis factor (TNF), interferon, interleukin 11, colony-forming factor, osteoprotegrin and interleukin 2 in E. coli. Furthermore, all expressed TNF fusion proteins can be detected by anti-TNF alpha antibody or by specific antibodies and purified by Ni(2+)-nitrilotriacetate beads. The expressed TNF fusion proteins can be cleaved by hydroxylamine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630898     DOI: 10.1042/ba20020070

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  3 in total

1.  A De Novo Optimized Cell-Free System for the Expression of Soluble and Active Human Tumor Necrosis Factor-Alpha.

Authors:  Nawal Abd El-Baky; Esmail M El-Fakharany; Soraya A Sabry; Ehab R El-Helow; Elrashdy Mustafa Redwan; Amira Sabry
Journal:  Biology (Basel)       Date:  2022-01-19

2.  Expression, purification, and characterization of recombinant protein GX1-rmhTNFalpha.

Authors:  Shanshan Cao; Yan Liu; Xiaohua Li; Yingqi Zhang; Jun Wang; Wenqi Du; Yu Han; Haifeng Jin; Lina Zhao; Kaichun Wu; Daiming Fan
Journal:  Mol Biotechnol       Date:  2009-04-09       Impact factor: 2.695

3.  A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy.

Authors:  Bei Chen; Shanshan Cao; Yingqi Zhang; Xin Wang; Jie Liu; Xiaoli Hui; Yi Wan; Wenqi Du; Li Wang; Kaichun Wu; Daiming Fan
Journal:  BMC Cell Biol       Date:  2009-09-09       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.